Seeking evaluation for bilateral pelvic discomfort, a female patient in her early thirties… — USMLE Step 2 CK

Seeking evaluation for bilateral pelvic discomfort, a female patient in her early thirties is seen at an ambulatory care clinic. The pain has steadily worsened over the past three days and is associated with a thick, yellow vaginal discharge. She has no significant past medical history and takes no daily medications other than a combined oral contraceptive pill. Her vital signs include a blood pressure of $118/76$ mmHg, a heart rate of $88$ /min, and a temperature of $38.1^\circ\text{C}$ ( $100.6^\circ\text{F}$ ). Abdominal examination reveals mild lower quadrant tenderness without guarding or rebound. Pelvic examination demonstrates mucopurulent discharge at the cervical os. Bimanual examination elicits significant pain upon manipulation of the cervix as well as bilateral adnexal tenderness. A point-of-care urine pregnancy test is negative. She is able to tolerate oral fluids in the clinic without nausea. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Administration of a single dose of intramuscular ceftriaxone, along with a 14-day course of oral doxycycline and oral metronidazoleAnswer
B
Hospital admission for intravenous administration of cefoxitin and oral doxycycline
C
Administration of a single dose of intramuscular ceftriaxone and a single dose of oral azithromycin
D
Initiation of a 14-day course of oral ciprofloxacin and oral metronidazole
E
Initiation of a 7-day course of oral metronidazole monotherapy

Answer

Administration of a single dose of intramuscular ceftriaxone, along with a 14-day course of oral doxycycline and oral metronidazole

The patient's clinical presentation is classic for acute pelvic inflammatory disease (PID). Because she is hemodynamically stable, tolerating oral intake, not pregnant, and lacks severe systemic illness or signs of a tubo-ovarian abscess, she qualifies for outpatient management. The standard-of-care outpatient regimen consists of intramuscular ceftriaxone (to cover Neisseria gonorrhoeae), oral doxycycline (to cover Chlamydia trachomatis), and oral metronidazole (to provide robust coverage against anaerobic organisms frequently involved in the polymicrobial pathogenesis of PID).

Step-by-Step Solution

Analyze the clinical presentation and physical examination findings.

The patient has fever, pelvic pain, mucopurulent cervical discharge, cervical motion tenderness, and adnexal tenderness.

These findings fulfill the diagnostic criteria for acute pelvic inflammatory disease (PID).

Determine the appropriate setting for care (inpatient vs. outpatient).

The patient is non-pregnant, lacks peritoneal signs or suspected tubo-ovarian abscess (TOA), and can tolerate oral fluids.

Patients with mild-to-moderate PID without indications for hospitalization can be safely managed in an outpatient setting.

Select the guideline-concordant empiric outpatient antibiotic regimen.

The correct regimen is a single dose of intramuscular ceftriaxone combined with 14 days of oral doxycycline and oral metronidazole.

This combination ensures comprehensive coverage of Neisseria gonorrhoeae, Chlamydia trachomatis, and anaerobes, aligning with current public health guidelines.

Key Concept

Outpatient management of Pelvic Inflammatory Disease (PID) requires empiric coverage for N. gonorrhoeae, C. trachomatis, and anaerobes using intramuscular ceftriaxone, oral doxycycline, and oral metronidazole.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic